Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VGB Ex01

Drug Profile

VGB Ex01

Alternative Names: Autologous CRISPR-Cas12b - Shanghai Vitalgen BioPharma; VGB Ex01 - autologous CRISPR-Cas12b; VGB-Ex01

Latest Information Update: 08 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Vitalgen BioPharma
  • Class Gene therapies; Haematopoietic stem cells therapies
  • Mechanism of Action Gene modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Clinical Phase Unknown Thalassaemia

Most Recent Events

  • 22 Sep 2023 Preclinical trials in Thalassaemia in China (Parenteral) prior to September 2023 (Shanghai Vitalgen Biopharma pipeline, September 2023)
  • 18 Sep 2023 Shanghai Vitalgen BioPharma in collaboration with Institute of Hematology & Blood Diseases Hospital plans a clinical trial for Thalassemia in China (NCT06041620)
  • 31 Aug 2023 Clinical trials in Thalassaemia (In children, In adults) in China (Parenteral) (NCT06041620)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top